Oral Contraceptives & Condom Market: An Analysis
Contraceptives are used for preventing pregnancy and are mainly of two types, hormonal methods and barrier methods, also called as devices. Oral contraceptives account for a major part of the contraceptives market.
Condoms and oral contraceptives are the two cornerstones of the contraceptive market. Although condoms are a type of contraceptives but these two are distinct and totally different segments of the market. Condoms are different from other contraceptives used by females in one aspect and that is their use for safety against the STDs. No other contraceptive method is effective in these areas and so in this area condoms have an added advantage over other contraceptives. On the contrary the use of condoms by men while having sex is not that high.
The oral contraceptives market consists of branded products and the generic versions of those brands. These brands, for example the leading Yasmin brand by Bayer, are facing a threat to its market by the generic drugs in the US market.
The contraceptives and condoms market is not so much affected or driven by the economic factors like the current economic downturn and are believed to hold up well in such tough times. However, this market tends to have a moderate and consistent growth rate. This market is more based on the demographic and sociological factors such as population growth, proportion of young population, perception of people about family planning and contraceptives, especially condoms.
This report talks about the contraceptives market, highlighting the various contraceptive methods used. The condom market, a part of the contraceptive market, is discussed in detail. The various growth drivers for contraceptives and condoms are discussed, while the effect of rising generics penetration in the oral contraceptives also pointed out. The major players in the contraceptive as well as condom market are profiled along with their key strategies.
Condoms and oral contraceptives are the two cornerstones of the contraceptive market. Although condoms are a type of contraceptives but these two are distinct and totally different segments of the market. Condoms are different from other contraceptives used by females in one aspect and that is their use for safety against the STDs. No other contraceptive method is effective in these areas and so in this area condoms have an added advantage over other contraceptives. On the contrary the use of condoms by men while having sex is not that high.
The oral contraceptives market consists of branded products and the generic versions of those brands. These brands, for example the leading Yasmin brand by Bayer, are facing a threat to its market by the generic drugs in the US market.
The contraceptives and condoms market is not so much affected or driven by the economic factors like the current economic downturn and are believed to hold up well in such tough times. However, this market tends to have a moderate and consistent growth rate. This market is more based on the demographic and sociological factors such as population growth, proportion of young population, perception of people about family planning and contraceptives, especially condoms.
This report talks about the contraceptives market, highlighting the various contraceptive methods used. The condom market, a part of the contraceptive market, is discussed in detail. The various growth drivers for contraceptives and condoms are discussed, while the effect of rising generics penetration in the oral contraceptives also pointed out. The major players in the contraceptive as well as condom market are profiled along with their key strategies.
1. CONTRACEPTIVE METHODS: AN OVERVIEW
Barrier Methods
Hormonal Methods
2. MARKET SIZE
2.1 Contraceptives Market
Female Contraceptives Market
Global Market by Region
Market Share
2.1.1 US Contraceptives Market
Market Share
Female Contraceptives Market by Value
Female Contraceptives Market by Volume
2.2 Condom Market
Market Share
North American Market
US Manufacturer Market
US Retail Market
3. GENERIC PENETRATION IN ORAL CONTRACEPTIVES
Global Generic Market by Region
Market Share
4. GROWTH DRIVERS
4.1 Population Control & Family Planning
4.2 Career Focus & Financial Independence
4.3 Increasing Awareness about AIDS & STDs
4.4 Enhanced Sexual Pleasure
4.5 Low Penetration in Developing Economies
5. CONDOM VS. CONTRACEPTIVES
6. COMPETITIVE LANDSCAPE
Comparison of Operating Metrics
7. COMPANY PROFILES
7.1 SSL International
Overview
Business Strategies
Consumer Insight-led Innovation
Cutting Edge Advertising
Efficient Business Practices
Acquisitions Fueling Growth
7.2 Ansell Limited
Overview
Business Strategies
Quality & Innovation
Market & Brand-driven Approach
Participation in Public Health
7.3 Bayer AG
Overview
Business Strategies
Strategy to Grow above Market Growth Rate
Increasing Corporate Value
7.4 Wyeth
Overview
Business Strategies
Strategic Collaborations
LIST OF TABLES
US Men’s Contraceptive Sales through Drug Stores by Players (2007-08)
US Men’s Contraceptive Unit Sales through Drug Stores by Players (2007-08)
Brand Vs Generic Market Value of Bayer’s Yasmin in US (2008-11E)
Impact of US Sales of Generic Forms of Yasmin and YAZ on Bayer Healthcare
Ranking of Major Generic Drug Makers (2007)
Competitive Operating Metrics (2007)
US Men’s Contraceptive Sales through Drug Stores by Players (2007-08)
US Men’s Contraceptive Unit Sales through Drug Stores by Players (2007-08)
Brand Vs Generic Market Value of Bayer’s Yasmin in US (2008-11E)
Impact of US Sales of Generic Forms of Yasmin and YAZ on Bayer Healthcare
Ranking of Major Generic Drug Makers (2007)
Competitive Operating Metrics (2007)
LIST OF CHARTS
Contraceptive Methods Chart
Women’s Preference Breakdown for Contraceptive Methods
Worldwide Growth of Female Contraceptives Market (2005-09E)
Global Contraceptives Market - Share of Major Regions (2007)
Global Contraceptives Market - Share of Major Players (2007)
Usage of Oral Contraceptives in Selected European Countries (2007)
Product Segments of Female Contraceptive Products Market (2007)
Market Share of US Oral Contraceptives Players (2007)
Market Share of Bayer’s YAZ in US Oral Contraceptives Market (2008)
US Women’s Contraceptives Market Share by Sales Value (2007-08)
US Women’s Contraceptives Market Share by Unit Sales (2007-08)
Global Condoms Market - Share of Major Players (2007)
Market Share of Extra Thin Condoms (2007)
North American Condoms Market - Share of Major Players (2007)
US Men’s Contraceptives Market Share by Sales Value (2007-08)
US Men’s Contraceptives Market Share by Unit Sales (2007-08)
Global Generic Market by Regions (2008 & 2013E)
US Generic Market Share by Total Rx (7/08)
Sales Growth of SSL’s Branded Condoms (2005-08)
Ansell’s Consumer Healthcare Segment Sales Growth (2004-08)
Bayer’s Pharmaceuticals & Biological Segment Sales Growth (2004-07)
Sales Growth of Wyeth’s Pharmaceuticals Segment (2004-08)
Contraceptive Methods Chart
Women’s Preference Breakdown for Contraceptive Methods
Worldwide Growth of Female Contraceptives Market (2005-09E)
Global Contraceptives Market - Share of Major Regions (2007)
Global Contraceptives Market - Share of Major Players (2007)
Usage of Oral Contraceptives in Selected European Countries (2007)
Product Segments of Female Contraceptive Products Market (2007)
Market Share of US Oral Contraceptives Players (2007)
Market Share of Bayer’s YAZ in US Oral Contraceptives Market (2008)
US Women’s Contraceptives Market Share by Sales Value (2007-08)
US Women’s Contraceptives Market Share by Unit Sales (2007-08)
Global Condoms Market - Share of Major Players (2007)
Market Share of Extra Thin Condoms (2007)
North American Condoms Market - Share of Major Players (2007)
US Men’s Contraceptives Market Share by Sales Value (2007-08)
US Men’s Contraceptives Market Share by Unit Sales (2007-08)
Global Generic Market by Regions (2008 & 2013E)
US Generic Market Share by Total Rx (7/08)
Sales Growth of SSL’s Branded Condoms (2005-08)
Ansell’s Consumer Healthcare Segment Sales Growth (2004-08)
Bayer’s Pharmaceuticals & Biological Segment Sales Growth (2004-07)
Sales Growth of Wyeth’s Pharmaceuticals Segment (2004-08)
